Crosstalk among IL-23 and DNAX activating protein of 12 kDa-Dependent pathways promotes osteoclastogenesis

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 316-324

  Shin, Hyun Seock ^a   Sarin, Ritu ^a   Dixit, Neha ^a   Wu, Jian ^b   Gershwin, Eric ^a   Bowman, Edward P ^c   Adamopoulos, Iannis E ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 23; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MEMBRANE PROTEIN; MYELOID DAP12 ASSOCIATED LECTIN 1; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE SYK; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CLEC5A PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; LECTIN; MULTIPROTEIN COMPLEX; NFATC1 PROTEIN, HUMAN; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SYK PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TYROBP PROTEIN, HUMAN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MACROPHAGE; OSTEOCLASTOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ARTHRITIS; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENZYME ACTIVATION; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MYELOID PROGENITOR CELL; OSTEOCLAST; PHOSPHORYLATION; PROTEIN QUATERNARY STRUCTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ARTHRITIS; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-23; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE PROTEINS; MULTIPROTEIN COMPLEXES; MYELOID PROGENITOR CELLS; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN-TYROSINE KINASES; RANK LIGAND; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; SYK KINASE;

EID: 84919628512     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401013     Document Type: Article

References (47)

1. Dale, D. C., L. Boxer, and W. C. Liles. 2008. The phagocytes: Neutrophils and monocytes. Blood 112: 935-945.
2. Wynn, T. A., A. Chawla, and J. W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature 496: 445-455.
3. Hume, D. A., and K. P. MacDonald. 2012. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119: 1810-1820.
4. Sarma, U., and A. M. Flanagan. 1996. Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 88: 2531-2540.
5. Fujikawa, Y., J. M. Quinn, A. Sabokbar, J. O. McGee, and N. A. Athanasou. 1996. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137: 4058-4060.
6. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
7. Schwarzenberger, P., V. La Russa, A. Miller, P. Ye, W. Huang, A. Zieske, S. Nelson, G. J. Bagby, D. Stoltz, R. L. Mynatt, et al. 1998. IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161: 6383-6389.
8. Pelletier, M., L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia, C. Costantini, L. Cosmi, C. Lunardi, F. Annunziato, S. Romagnani, and M. A. Cassatella. 2010. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343.
9. Liu, B., W. Tan, A. Barsoum, X. Gu, K. Chen, W. Huang, A. Ramsay, J. K. Kolls, and P. Schwarzenberger. 2010. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement. Exper. Hematol. 38: 877-884.e871.
10. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23∗01: 233-240.
11. Adamopoulos, I. E., M. Tessmer, C. C. Chao, S. Adda, D. Gorman, M. Petro, C. C. Chou, R. H. Pierce, W. Yao, N. E. Lane, et al. 2011. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J. Immunol. 187: 951-959.
12. Parham, C., M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K. P. Singh, F. Vega, et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168: 5699-5708.
13. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23∗01: 4560-4565.
14. Awasthi, A., L. Riol-Blanco, A. Jäger, T. Korn, C. Pot, G. Galileos, E. Bettelli, V. K. Kuchroo, and M. Oukka. 2009. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182: 5904-5908.
15. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
16. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763.
17. Kaifu, T., J. Nakahara, M. Inui, K. Mishima, T. Momiyama, M. Kaji, A. Sugahara, H. Koito, A. Ujike-Asai, A. Nakamura, et al. 2003. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111: 323-332.
18. Bakker, A. B., E. Baker, G. R. Sutherland, J. H. Phillips, and L. L. Lanier. 1999. Myeloid DAP12-Associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. USA 96: 9792-9796.
19. Ivashkiv, L. B. 2008. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nat. Rev. Immunol. 8: 816-822.
20. Wang, L., I. Tassiulas, K. H. Park-Min, A. C. Reid, H. Gil-Henn, J. Schlessinger, R. Baron, J. J. Zhang, and L. B. Ivashkiv. 2008. 'Tuning' of type I interferoninduced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat. Immunol. 9: 186-193.
21. Mócsai, A., M. B. Humphrey, J. A. Van Ziffle, Y. Hu, A. Burghardt, S. C. Spusta, S. Majumdar, L. L. Lanier, C. A. Lowell, and M. C. Nakamura. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101: 6158-6163.
22. Lanier, L. L., and A. B. Bakker. 2000. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 21: 611-614.
23. Colonna, M. 2003. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3: 445-453.
24. Humphrey, M. B., K. Ogasawara, W. Yao, S. C. Spusta, M. R. Daws, N. E. Lane, L. L. Lanier, and M. C. Nakamura. 2004. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J. Bone Miner. Res. 19: 224-234.
25. Zou, W., H. Kitaura, J. Reeve, F. Long, V. L. Tybulewicz, S. J. Shattil, M. H. Ginsberg, F. P. Ross, and S. L. Teitelbaum. 2007. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176: 877-888.
26. Zou, W., J. L. Reeve, Y. Liu, S. L. Teitelbaum, and F. P. Ross. 2008. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol. Cell 31: 422-431.
27. Adamopoulos, I. E., A. Sabokbar, B. P. Wordsworth, A. Carr, D. J. Ferguson, and N. A. Athanasou. 2006. Synovial fluid macrophages are capable of osteoclast formation and resorption. J. Pathol. 208: 35-43.
28. Nesbitt, S. A., and M. A. Horton. 1997. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276: 266-269.
29. Follenzi, A., and L. Naldini. 2002. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol. 346: 454-465.
30. Kudo, O., A. Sabokbar, A. Pocock, I. Itonaga, Y. Fujikawa, and N. A. Athanasou. 2003. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32: 1-7.
31. Cua, D. J., and C. M. Tato. 2010. Innate IL-17-producing cells: The sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
32. Adamopoulos, I. E., C. C. Chao, R. Geissler, D. Laface, W. Blumenschein, Y. Iwakura, T. McClanahan, and E. P. Bowman. 2010. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res. Ther. 12: R29.
33. Joyce-Shaikh, B., M. E. Bigler, C. C. Chao, E. E. Murphy, W. M. Blumenschein, I. E. Adamopoulos, P. G. Heyworth, S. Antonenko, E. P. Bowman, T. K. McClanahan, et al. 2010. Myeloid DAP12-Associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J. Exp. Med. 207: 579-589.
34. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
35. Batliner, J., M. M. Mancarelli, M. Jenal, V. A. Reddy, M. F. Fey, B. E. Torbett, and M. P. Tschan. 2011. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. Mol. Immunol. 48: 714-719.
36. Charles, J. F., L. Y. Hsu, E. C. Niemi, A. Weiss, A. O. Aliprantis, and M. C. Nakamura. 2012. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J. Clin. Invest. 122: 4592-4605.
37. Mao, D., H. Epple, B. Uthgenannt, D. V. Novack, and R. Faccio. 2006. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116: 2869-2879.
38. Ortaldo, J. R., R. Winkler-Pickett, J. Wigginton, M. Horner, E. W. Bere, A. T. Mason, N. Bhat, J. Cherry, M. Sanford, D. L. Hodge, and H. A. Young. 2006. Regulation of ITAM-positive receptors: Role of IL-12 and IL-18. Blood 107: 1468-1475.
39. Colucci, F. 2007. Unexpected partnership between IL-15 and DAP10. Nat. Immunol. 8: 1289-1291.
40. Inui, M., Y. Kikuchi, N. Aoki, S. Endo, T. Maeda, A. Sugahara-Tobinai, S. Fujimura, A. Nakamura, A. Kumanogoh, M. Colonna, and T. Takai. 2009. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl. Acad. Sci. USA 106: 4816-4821.
41. Yarilina, A., K. Xu, J. Chen, and L. B. Ivashkiv. 2011. TNF activates calciumnuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl. Acad. Sci. USA 108: 1573-1578.
42. Aliprantis, A. O., Y. Ueki, R. Sulyanto, A. Park, K. S. Sigrist, S. M. Sharma, M. C. Ostrowski, B. R. Olsen, and L. H. Glimcher. 2008. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118: 3775-3789.
43. Kamolmatyakul, S., W. Chen, and Y. P. Li. 2001. Interferon-gamma downregulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation. J. Dent. Res. 80: 351-355.
44. Atkins, G. J., P. Kostakis, C. Vincent, A. N. Farrugia, J. P. Houchins, D. M. Findlay, A. Evdokiou, and A. C. Zannettino. 2006. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J. Bone Miner. Res. 21: 1339-1349.
45. Yago, T., Y. Nanke, M. Kawamoto, T. Furuya, T. Kobashigawa, N. Kamatani, and S. Kotake. 2007. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res. Ther. 9: R96.
46. Moon, S. J., I. E. Ahn, H. Jung, H. Yi, J. Kim, Y. Kim, S. K. Kwok, K. S. Park, J. K. Min, S. H. Park, et al. 2013. Temporal differential effects of proinflammatory cytokines on osteoclastogenesis. Int. J. Mol. Med. 31: 769-777.
47. Chen, L., X. Q. Wei, B. Evans, W. Jiang, and D. Aeschlimann. 2008. IL-23 promotes osteoclast formation by up-regulation of receptor activator of NFkappaB (RANK) expression in myeloid precursor cells. Eur. J. Immunol. 38: 2845-2854.